More than 100 pharmaceutical drugs are facing supply chain shortages, according to the FDA.
Drugs currently listed as “in shortage” include antidepressants, antibiotics, heart medicines, cancer-fighting drugs and painkillers, Just the News reports.
“The FDA continues to take steps to monitor the supply chain,” the FDA wrote.
“The Drug Shortage Staff within the FDA’s Center for Drug Evaluation and Research has asked manufacturers to evaluate their entire supply chain, including active pharmaceutical ingredients, finished dose forms, and any components that may be impacted in any area of the supply chain due to the COVID-19 outbreak,” the FDA wrote in a statement.
The FDA reported that around 80 percent of pharmaceutical ingredient manufacturers are located outside of the United States.
60 percent of pharmacies reported having supply chain disruptions.